Vaccine developer & Lonza partner Moderna moves to Basel

Countries around the world are in the race for the first corona vaccine. According to the World Health Organization (WHO), 165 vaccines are currently in test and study phases. No drug has so far proven that it protects against Covid-19, let alone that it can be used in humans.

The US pharmaceutical company Moderna is one of the most promising candidates to be the first to launch an effective vaccine on the market. As «CH Media» reports, the US company is now opening tents in Switzerland, specifically in Basel. This is said to be close to Lonza, the pharmaceutical supplier in Basel, who is to manufacture the active ingredient.

Share on facebook
Share on pinterest
Share on twitter
Share on linkedin
Share on email


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.